RKVTF (Rakovina Therapeutics) Common Stock: $14.02 Mil (As of Mar. 2026)


RKVTF Rakovina Therapeutics Inc RKVTF
27 GF Score
Price $0.09
! 1 Warning Sign
View Full Analysis

What is Rakovina Therapeutics Common Stock?

Rakovina Therapeutics RKVTF -5.71% 27 Common Stock is $14.02 Mil as of Mar. 2026. GuruFocus rates RKVTF with a GF Score™ of 27/100. The stock has 1 warning sign investors should review.

Rakovina Therapeutics's quarterly common stock increased from Sep. 2025 ($13.34 Mil) to Dec. 2025 ($13.59 Mil) and increased from Dec. 2025 ($13.59 Mil) to Mar. 2026 ($14.02 Mil).

Rakovina Therapeutics's annual common stock increased from Dec. 2023 ($10.14 Mil) to Dec. 2024 ($11.55 Mil) and increased from Dec. 2024 ($11.55 Mil) to Dec. 2025 ($13.59 Mil).

Rakovina Therapeutics Common Stock Historical Data

* Premium members only.

The historical data trend for Rakovina Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rakovina Therapeutics Common Stock Chart

Rakovina Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
10.61 10.00 10.14 11.55 13.59

Rakovina Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.50 13.50 13.34 13.59 14.02
RKVTF
27GF Score
Rakovina Therapeutics Inc RKVTF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rakovina Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $14.02 Mil mean?
Rakovina Therapeutics (RKVTF) has a Common Stock of $14.02 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Rakovina Therapeutics and its competitors.
Is Rakovina Therapeutics' Common Stock too high?
Rakovina Therapeutics' current Common Stock is $14.02 Mil. Overall, Rakovina Therapeutics has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Rakovina Therapeutics' Common Stock compare to VRTX and REGN?
Rakovina Therapeutics' Common Stock of $14.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Rakovina Therapeutics and its competitors. Rakovina Therapeutics's current Common Stock is $14.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rakovina Therapeutics stock overvalued right now?
Rakovina Therapeutics (RKVTF) has a current Common Stock of $14.02 Mil. The current Common Stock is $14.02 Mil. Rakovina Therapeutics' overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Rakovina Therapeutics (RKVTF), the current Common Stock is $14.02 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rakovina Therapeutics Business Description

Other Exchanges 7JO0:GermanyRKV:Canada
Address 999 West Broadway, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a greater pace. The company has established a pipeline of distinctive DNA-damage response inhibitors to advance one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners. Its drug development pipeline consists of candidates like kt-5000AI, kt-2000AI, and kt-3283, targeting solid tumours and PARP-resistant adult and childhood cancers.
27GF Score

Get the complete analysis for RKVTF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price